Research library
Recent Publications
84 entries from 2015 to 2026.
2026
A Multicenter Kidney Transplantation Study Identifies Hierarchy and Directionality of HLA-DQ Alloimmune Responses
Nat Commun. 2026 August, https://doi.org/10.1038/s41467-026-76912-7
Sensitization in Organ Transplantation: Assessment of Risk (STAR) 2025 meeting group report
Am J Transplant. 2026 May, 26(5):1048-1069. PMID: 41519473. doi: 10.1016/j.ajt.2025.12.286
The Alpha-beta Soup of HLA-DQ: A Recipe for Alloimmune Perspectives
Transplantation. 2026 Jun 16; PMID: 42302258. doi: 10.1097/TP.0000000000005817.
Not All Mismatches Were Created Equal: Empirical Identification of Regions Within HLA-DQ Molecules that Harbor the Highest Immunogenicity
Transplantation. 2026 Jan; PMID: 41543939. doi: 10.1097/TP.0000000000005609
2025
Blind Spots in HLA Class II Detection Generate Challenges for Antibody and RNA-based Assays
Transplantation. 2025 Dec 5; 110(5):e952–e955; PMID: 41347926; doi: 10.1097/TP.0000000000005592
Recipient Human Leukocyte Antigen-DR Homozygosity and Access to Quality Kidneys
Kidney Int Rep. 2025 Nov;11(2):103678. PMID: 41502812. doi:10.1016/j.ekir.2025.11.005
Donor-recipient mismatch at the SIRPA locus adversely affects kidney allograft outcomes
Sci Transl Med. 2025 Jul; 17(807):eady1135. PMID:40668892. doi:10.1126/scitranslmed.ady1135.
Sensitization in Transplantation Assessment of Risk 2025 innate working group: The potential role of innate allorecognition in kidney allograft damage
Am J Transplant. 2025 Oct;25(10):2038-2047. PMID:40623504. doi:10.1016/j.ajt.2025.06.030.
Summary of the International Society for Heart and Lung Transplantation consensus conference on emerging understanding of antibodies and antibody-mediated rejection in heart transplantation
J Heart Lung Transplant. 2025 Aug;44(8):e1-e20. PMID:40498433. doi:10.1016/j.healun.2025.02.1690.
Spatial transcriptomics of Glomerulo-centric antibody mediated rejection in renal transplants
Clin Immunol. 2025 May;274:110460. PMID:39993695. doi:10.1016/j.clim.2025.110460.
The Impact of HLA-DQαβ Heterodimer Mismatch on Living Donor Kidney Allograft Outcomes
Transplantation 2025 Apr; 109(4):720-728. PMID:39233325. doi: 10.1097/TP.0000000000005198.
Anti-HLA serologic response to CD38-targeting desensitization therapy is challenged by peripheral memory B cells in highly sensitized kidney transplant candidates
Am J Transplantation 2025 Jan; 25(1): 88-101. PMID:39134120. doi: 10.1016/j.ajt.2024.08.004.
2024
Calibration of Priority Points for Sensitization Status of Kidney Transplant Candidates in the United States
Clin J Am Soc Nephrol. 2024 Jun:19(6):767-777. PMID: 38509037. doi: 10.2215/CJN.0000000000000449.
Commentary on review: Forming new perspective approaches to determination of donor compatibility
Int J Immunogenetics. 2024 Aug; 51(4):252-253. PMID:38794787. doi.org/10.1111/iji.12680.
Sensitive HLA antibody testing and the risk of antibody-mediated rejection and graft failure
HLA 2024 Jun;103(6):e15586. PMID:38932739. doi: 10.1111/tan.15586.
HLA molecular mismatches and induced donor-specific tolerance in combined living donor kidney and hematopoietic stem cell transplantation
Front Immunol. 2024 Mar 27:15:1377535. PMID: 38601147. doi: 10.3389/fimmu.2024.1377535.
HLA (emphasis on DQ) compatibility for longer allograft survival in pediatric transplantation: Modern evidence and challenges
Pediatr Transplant. 2024 Feb;28(1):e14606. PMID: 37716000. doi:10.1111/petr.14606.
Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney Transplant
J Am Soc Nephrol. 2024 Mar;35(3):347-360. PMID: 38147137. doi: 10.1681/ASN.0000000000000287.
Compartmentalization of Transcripts During Antibody Mediated Rejection in Renal Transplants
BioRxiv. 2024.05.20.594331. doi:10.1101/2024.05.20.594331.
Qualitative, rather than quantitative, differences between HLA-DQ alleles affect HLA-DQ immunogenicity in organ transplantation
HLA 2024 Apr;103(4):315455. PMID:38575370. doi:10.1111/tan.15455.Wiley HLA: The Best Paper Award and Top Cited Article for Year 2024
The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics
Am J Transplant. 2024 Mar;24(3):338-349. PMID:38032300. doi:10.1016/j.ajt.2023.10.016.
2023
HLA-DQ antibodies in alloimmunity, what makes them different?
Curr Opin Organ Transplant 2023 Oct;28(5):333-339. PMID:37219535. doi:10.1097/MOT.0000000000001079.
Inspirational Stories: My life in HLA
ASHI Quarterly, First Quarter 2023.
Clinical recommendations for posttransplant assessment of anti-HLA (Human Leukocyte Antigen) donor-specific antibodies: A Sensitization in Transplantation: Assessment of Risk consensus document
Am J Transplant. 2023 Jan;23(1):115-132. PMID:36695614. doi:10.1016/j.ajt.2022.11.013.
Sensitization in Transplantation: Assessment of Risk 2022 Working Group Meeting Report
Am J Transplant. 2023 Jan;23(1):133-149. PMID:36695615. doi:10.1016/j.ajt.2022.11.009.
Improving equity in kidney transplant allocation policies through a novel genetic metric: The Matched Donor Potential
Am J Transplant. 2023 Jan;23(1):45-54. PMID:36695620. doi:10.1016/j.ajt.2022.08.001.
The evolving use of biomarkers in heart transplantation: Consensus of an expert panel
Am J Transplant. 2023 Jun;23(6):727-735. PMID:36870390. doi: 10.1016/j.ajt.2023.02.025.
Development of de novo donor-specific antibodies in renal transplant recipients with BK viremia managed with immunosuppression reduction
Transpl Infect Dis. 2023 Feb;25(1):e13993. PMID:36413505. doi: 10.1111/tid.13993
Can We Use Eplets (or Molecular) Mismatch Load Analysis to Improve Organ Allocation? The Hope and the Hype
Transplantation 2023 Mar;107(3):605-615. PMID:36163639. doi:10.1097/TP.0000000000004307.
Potential Implication of HLA-DQ Heterodimer High-Resolution Typing on Kidney Transplant Outcomes and Equity
Current Transplant Reports 2023 Aug;10(4):1-7. doi: 10.1007/s40472-023-00407-3.
2022
HLA-DQ Mismatches Lead to More Unacceptable Antigens, Greater Sensitization, and Increased Disparities in Repeat Transplant Candidates
J Am Soc Nephrol. 2022 Dec;33(12):2293-2305. PMID: 36450598. doi: 10.1681/ASN.2022030296.Best of the American Society of Nephrology (ASN) Journals Award 2022
Clinical utility of serial serum dilutions for HLA antibody interpretation
HLA 2022 Nov;100(5):457-468. PMID:35986896. doi:10.1111/tan.14781
Assessment of Virological Contributions to COVID-19 Outcomes in a Longitudinal Cohort of Hospitalized Adults
Open Forum Infect Dis. 2022 Feb;9(3):ofac027. PMID:35198645. doi: 10.1093/ofid/ofac027.
Molecular Histocompatibility Beyond Tears: The next generation version
Hum Immunol. 2022 Mar;83(3):233-240. PMID:35067388. doi:10.1016/j.humimm.2021.12.005.
2021
Significance of HLA-DQ in kidney transplantation: time to reevaluate human leukocyte antigen-matching priorities to improve transplant outcomes? An expert review and recommendations
Kidney Int. 2021 Nov; 100(5):1012-1022. PMID:34246656. doi: 10.1016/j.kint.2021.06.026.
Apples, oranges, and anything in between: In search of the best desensitization therapy
Am J Transplant. 2021 Dec; 21(12):3825-3826. PMID: 34416097. doi:10.1111/ajt.16808.
Assessment and Modeling of COVID-19 Outcomes in a Longitudinal Cohort of Hospitalized Adults
MedRxiv 2021.07.02.21259665. doi: https://doi.org/10.1101/2021.07.02.21259665.
Impact of SIRPα polymorphism on transplant outcomes in HLA-identical living donor kidney transplantation
Clin Transplant. 2021 Sep;35(9):e14406. PMID:34180101. doi:10.1111/ctr.14406.
Accurate eplet identification is necessary for accurate risk assessment
Am J Transplant. 2021 Oct;21(10):3504. PMID:33866684. doi:10.1111/ajt.16612.
Current Approaches to Desensitization in Solid Organ Transplantation
Front Immunol. 2021 May; 12:686271. PMID:34046044. doi: 10.3389/fimmu.2021.686271.
Innate-like self-reactive B cells infiltrate human renal allograft during transplant rejection
Nat Commun. 2021 Jul;12(1):4372. PMID:34272370. doi:10.1038/s41467-021-24615-6.
Substituting imputation of HLA antigens for high-resolution HLA typing: Evaluation of a multiethnic population and implications for clinical decision making in transplantation
Am J Transplant. 2021 Jan;21(1):344-352. PMID:32430947. doi:10.1111/ajt.16070.
Outcomes of repeat kidney transplantation following prior graft failure secondary to BK nephropathy: A single center retrospective study
Transpl Infect Dis. 2021 Aug;23(4):e13672. PMID: 34153164. doi: 10.1111/tid.13672.
Immune and gene expression profiling during tacrolimus to everolimus conversion early after liver transplantation
Hum Immunol. 2021 Feb;82(2): 81-88. PMID: 33213941. doi: 10.1016/j.humimm.2020.10.012.
Estimating alloantibody levels in highly sensitized renal allograft candidates: Using serial dilutions to demonstrate a treatment effect in clinical trials
Am J Transplant. 2021 Mar;21(3):1278-1284. PMID: 33078553. doi:10.1111/ajt.16363.
2020
Measuring human leukocyte antigen alloantibodies: beyond a binary decision
Curr Opin Organ Transplant. 2020 Dec;25(6):529-535. PMID: 33055530. doi: 10.1097/MOT.0000000000000822.
Sensitization in Transplantation: Assessment of Risk (STAR) 2019 Working Group Meeting Report
Am J Transplant. 2020 Oct;20(10):2652-2668. PMID: 32342639. doi: 10.1111/ajt.15937.
Eplet Mismatch Load and De Novo Occurrence of Donor-Specific Anti-HLA Antibodies, Rejection, and Graft Failure after Kidney Transplantation: An Observational Cohort Study
J Am Soc Nephrol. 2020 Sep;31(9):2193-2204. PMID:32764139. doi:10.1681/ASN.2020010019.
The shared epitope phenomenon – A potential impediment to virtual crossmatch accuracy
Clin Transplant. 2020 Aug;34(8):e13906. PMID: 32418254. doi:10.1111/ctr.13906.
Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantation Society Working Group
Transplantation. 2020 May;104(5):911-922. PMID:31895348. doi:10.1097/TP.0000000000003095.
Virtual crossmatching for deceased donor transplantation: one size does not fit all
Kidney Int. 2020 Apr;97(4):659-662. PMID:32200862. doi: 10.1016/j.kint.2020.02.001.
A blueprint for electronic utilization of ambiguous molecular HLA typing data in organ allocation systems and virtual crossmatch
Human Immunol. 2020 Feb-Mar;81(2-3):65-72. PMID:32057520. doi: 10.1016/j.humimm.2020.01.007.
Measuring human leukocyte antigen alloantibodies: beyond a binary decision
Curr Opin Organ Transplant. 2020 Dec;25(6):529-535. PMID:33055530. doi:10.1097/MOT.0000000000000822.
Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus from The Transplantation Society Working Group
Transplantation. 2020 May;104(5):911-922. PMID:31895348. doi:10.1097/TP.0000000000003095.
2019
Predicting kidney transplant outcomes with partial knowledge of HLA mismatch
Proc Natl Acad Sci U S A. 2019 Oct;116(41):20339-20345. PMID31548419. doi:10.1073/pnas.1911281116.
Prognostic tools to assess candidacy for and efficacy of antibody-removal therapy
Am J Transplant. 2019 Feb;19(2):381-390. PMID:29981209. doi:10.1111/ajt.15007.
The quest to decipher HLA immunogenicity: Telling friend from foe
Am J Transplant. 2019 June;19(5):2910-2925. doi:10.1111/ajt.15489. American Journal of Transplantation (AJT) top 10 articles of 2019
2018
HLA-Epitope Matching or Eplet Risk Stratification: The Devil Is in the Details
Front. Immunol. 2018 Aug:9:2010. PMID:30233594. doi:10.3389/fimmu.2018.02010.
Human leukocyte antigen matching in organ transplantation: what we know and how can we make it better (Revisiting the past, improving the future)
Curr Opin Organ Transplant. 2018 Aug;23(4):470-476. PMID:29750676. doi:10.1097/MOT.0000000000000538.
A Call for Action – The transplant recipient’s expectation of precision in transplant medicine
Am J Transplant. 2018 Dec;18(12):2845-2846. PMID:30022602. doi:10.1111/ajt.15027.
Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report
Am J Transplant. 2018 Jul;18(7):1604-1614. PMID:29603613. doi:10.1111/ajt.14752.
Updated follow-up of a tolerance protocol in HLA-identical renal transplant pairs given donor hematopoietic stem cells
Human Immunol. 2018 May;79(5):277-282. PMID:29408689. doi:10.1016/j.humimm.2018.01.010.
HLA Diagnostics: Evaluating DSA Strength by Titration
Transplantation. 2018 Jan;102(1S Suppl 1):S23-S30. PMID:29266059. doi:10.1097/TP.0000000000001817.
HLA Antibody Quantification by Titration
ASHI Quarterly, Second Quarter 2018.
2017
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology
Am J Transplant. 2017 Jan; 17(1):28-41. PMID:27862883. doi:10.1111/ajt.14107.
Harnessing Scientific and Technological Advances to Improve Equity in Kidney Allocation Policies
Am J Transplant. 2017 Dec;17(12):3149-3158. PMID:28597555. doi:10.1111/ajt.14389.
Assessing the potential of angiotensin II type 1 receptor and donor specific anti-endothelial cell antibodies to predict long-term kidney graft outcome
Human Immunol. 2017 May-Jun;78(5-6):421-427. PMID:28372986. doi:10.1016/j.humimm.2017.03.012.
2016
HLA Epitopes – Are We Ready for Clinical Prime Time? Historic Perspective and Future Needs
Clin Transpl. 2016;32:63-71. PMID:28564523.
Donor-Specific HLA Antibodies in Living Versus Deceased Donor Liver Transplant Recipients
Am J Transplant. 2016 Aug;16(8):2437–2444. PMID:26896194. doi:10.1111/ajt.13757.
HLA-DQ antibodies: are they real? Are they relevant? Why so many?
Curr Opin Organ Transplant. 2016 Aug;21(4):441-446. PMID:27200497. doi:10.1097/MOT.0000000000000325.
Auto- and allo-epitopes in DQ alloreactive antibodies
Curr Opin Organ Transplant. 2016 Aug;21(4):355-361. PMID:27224442. doi:10.1097/MOT.0000000000000327.
Hiding in Plain Sight – A New Look at HLA Epitopes: A Case Report
Am J Transplant. 2016 Nov;16(11):3286-3291. PMID:27289077. doi:10.1111/ajt.13918.
Can solid phase assays be better utilized to measure efficacy of antibody removal therapies?
Human Immunol. 2016 Aug;77(8):624-630. PMID:27267046. doi:10.1016/j.humimm.2016.05.025.
Incorporating human leukocyte antibody results into clinical practice
J Heart Lung Transplant. 2016 Jul;35(7):851-856. PMID:27338026. doi:10.1016/j.healun.2016.05.010.
Humoral Human Lung Allograft Rejection by Tissue-Restricted Non-HLA Antibodies
Ann Thorac Surg. 2016 Oct;102(4):e339-341. PMID:27645977. doi:10.1016/j.athoracsur.2016.03.042.
Nonchimeric HLA-Identical Renal Transplant Tolerance: Regulatory Immunophenotypic/Genomic Biomarkers
Am J Transplant. 2016 Jan; 16(1):221-234. PMID:26227106. doi:10.1111/ajt.13416.
2015
Advancing Histocompatibility Testing for Solid Organ Transplantation – What is Needed? A Personal Opinion
Clin Transpl. 2015:31:193-201. PMID:28514581.
High-Resolution HLA Typing for Sensitized Patients: Advances in Medicine and Science Require Us to Challenge Existing Paradigms
Am J Transplant. 2015 Oct;15(10):2780-2781. PMID:26177785. doi:10.1111/ajt.13376.
Unintended Consequences of the New National Kidney Allocation Policy in the United States
Am J Transplant. 2015 Sep;15(9):2465-2469. PMID:26137963. doi:10.1111/ajt.13381.
Assessing Antibody Strength: Comparison of MFI, C1q, and Titer Information
Am J Transplant. 2015 Sep;15(9):2421-2430. PMID:25930984. doi:10.1111/ajt.13295.
Stratifying Patients Based on Epitope Mismatching: Ready for Primetime?
Am J Transplant. 2015 Aug;15(8):2021-2022. PMID:26095902. doi:10.1111/ajt.13343.
Real-time qPCR for chimerism assessment in allogeneic hematopoietic stem cell transplants from unrelated adult and double umbilical cord blood
Human Immunol. 2015 Mar;76(2-3):155-160. PMID:25636574. doi:10.1016/j.humimm.2015.01.007.
Should HLA Mismatch Acceptability for Sensitized Transplant Candidates Be Determined at the High-Resolution Rather Than the Antigen Level?
Am J Transplant. 2015 Apr;15(4):923-930. PMID:25778447. doi:10.1111/ajt.13167.
HLA epitopes as viewed by antibodies: what is it all about?
Am J Transplant. 2015 May;15(5):1148-1152. PMID:25708017. doi:10.1111/ajt.13192.
No publications match your search.